KHK6640
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for KHK6640, covering 2016-12-07 to 2024-06-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease [Phase 1]